32 results on '"Lanati, E."'
Search Results
2. Valutazione economica di un programma di screening anti-HCV in Italia
3. The burden of atopic dermatitis in adults in Italy
4. PMU44 FIFTY SHADES OF... INNOVATIVENESS IN ITALY
5. PMU46 POSITIVE IMPACT OF INNOVATIVE STATUS IN P&R PROCESS TIMING IN ITALY
6. PMU49 NEGOTIATION OUTCOMES IN ITALY: WHAT’S THE IMPACT OF ORPHAN DRUG DESIGNATION?
7. PMU65 PRICE ANALYSIS OF NEW MEDICINAL PRODUCTS REIMBURSED IN ITALY AND GERMANY
8. PMU45 PREVALENCE VS. TREATMENT COST: ANALYSIS OF DRUGS FOR RARE DISEASE IN ITALY
9. PMU47 ORPHAN DRUG DESIGNATION: NO IMPACT ON P&R PROCESS TIMING IN ITALY
10. PMU48 P&R PROCESS IN ITALY: A FOCUS ON NEGOTIATION OUTCOMES OF INNOVATIVE DRUGS
11. Persistence on apixaban in atrial fibrillation patients: A retrospective multicentre study
12. Primary Biliary Cholangitis: advances in management and treatment of the disease
13. The qPMO project: applying Quality principles and methodologies in Life Sciences research
14. Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines
15. Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers
16. HCV – Treatment ratio and governance footprints: analysis of regional differentiation in Italy.
17. Primary Biliary Cholangitis: advances in management and treatment of the disease
18. Proton Pump Inhibitors In Italy: It's Time to Make A (Policy) Change.
19. Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy.
20. Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study
21. X-linked hypophosphatemic rickets: an Italian experts' opinion survey
22. Nutritional Aspects And Disinformation In Liver Disease: A Questionnaire-Based Survey In Italian Patients
23. Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers
24. Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan).
25. Nutritional Aspects And Disinformation In Liver Disease: A Questionnaire-Based Survey In Italian Patients.
26. Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
27. Le tempistiche autorizzative di AIFA: un confronto tra le due commissioni consultive e tecnico-scientifiche succedutesi nel periodo 2015-2020.
28. Primary Biliary Cholangitis: advances in management and treatment of the disease.
29. HCV - Estimation of the number of diagnosed patients eligible to the new anti-HCV therapies in Italy.
30. Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines.
31. Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers.
32. Economic Evaluation of Agomelatine for Major Depressive Disorders Relative to other Antidepressants in the Italian Setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.